173 related articles for article (PubMed ID: 32971160)
1. Paeonia lactiflora extract suppresses cisplatin-induced muscle wasting via downregulation of muscle-specific ubiquitin E3 ligases, NF-κB signaling, and cytokine levels.
Jang J; Lee H; Song J; Bae T; Park M; Kwon YV; Lee D; Yoon Y
J Ethnopharmacol; 2021 Feb; 266():113403. PubMed ID: 32971160
[TBL] [Abstract][Full Text] [Related]
2. Paeonia lactiflora root extract suppresses cancer cachexia by down-regulating muscular NF-κB signalling and muscle-specific E3 ubiquitin ligases in cancer-bearing mice.
Bae T; Jang J; Lee H; Song J; Chae S; Park M; Son CG; Yoon S; Yoon Y
J Ethnopharmacol; 2020 Jan; 246():112222. PubMed ID: 31505213
[TBL] [Abstract][Full Text] [Related]
3. Paeonia lactiflora extract improves the muscle function of mdx mice, an animal model of Duchenne muscular dystrophy, via downregulating the high mobility group box 1 protein.
Sim I; Jang J; Song J; Lee J; Lim H; Lee HJ; Hwang G; Kwon YV; Lee D; Yoon Y
J Ethnopharmacol; 2022 May; 289():115079. PubMed ID: 35149132
[TBL] [Abstract][Full Text] [Related]
4. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model.
Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG
J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652
[TBL] [Abstract][Full Text] [Related]
5. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.
Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y
Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270
[TBL] [Abstract][Full Text] [Related]
6. Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway.
Ikeda Y; Imao M; Satoh A; Watanabe H; Hamano H; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
J Trace Elem Med Biol; 2016 May; 35():66-76. PubMed ID: 27049128
[TBL] [Abstract][Full Text] [Related]
7. Triptolide prevents LPS-induced skeletal muscle atrophy via inhibiting NF-κB/TNF-α and regulating protein synthesis/degradation pathway.
Fang WY; Tseng YT; Lee TY; Fu YC; Chang WH; Lo WW; Lin CL; Lo YC
Br J Pharmacol; 2021 Aug; 178(15):2998-3016. PubMed ID: 33788266
[TBL] [Abstract][Full Text] [Related]
8. NF-κB activation is required for the transition of pulmonary inflammation to muscle atrophy.
Langen RC; Haegens A; Vernooy JH; Wouters EF; de Winther MP; Carlsen H; Steele C; Shoelson SE; Schols AM
Am J Respir Cell Mol Biol; 2012 Sep; 47(3):288-97. PubMed ID: 22538866
[TBL] [Abstract][Full Text] [Related]
9. Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.
Paul PK; Gupta SK; Bhatnagar S; Panguluri SK; Darnay BG; Choi Y; Kumar A
J Cell Biol; 2010 Dec; 191(7):1395-411. PubMed ID: 21187332
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia.
Wang H; Lai YJ; Chan YL; Li TL; Wu CJ
Cancer Lett; 2011 Jun; 305(1):40-9. PubMed ID: 21397390
[TBL] [Abstract][Full Text] [Related]
11. Curcumin prevents lipopolysaccharide-induced atrogin-1/MAFbx upregulation and muscle mass loss.
Jin B; Li YP
J Cell Biochem; 2007 Mar; 100(4):960-9. PubMed ID: 17131360
[TBL] [Abstract][Full Text] [Related]
12. Endotoxin-induced skeletal muscle wasting is prevented by angiotensin-(1-7) through a p38 MAPK-dependent mechanism.
Morales MG; Olguín H; Di Capua G; Brandan E; Simon F; Cabello-Verrugio C
Clin Sci (Lond); 2015 Sep; 129(6):461-76. PubMed ID: 25989282
[TBL] [Abstract][Full Text] [Related]
13. Protein therapy of skeletal muscle atrophy and mechanism by angiogenic factor AGGF1.
He Z; Song Q; Yu Y; Liu F; Zhao J; Un W; Da X; Xu C; Yao Y; Wang QK
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):978-991. PubMed ID: 36696895
[TBL] [Abstract][Full Text] [Related]
14. STZ-induced skeletal muscle atrophy is associated with increased p65 content and downregulation of insulin pathway without NF-κB canonical cascade activation.
Kelleher AR; Fairchild TJ; Keslacy S
Acta Diabetol; 2010 Dec; 47(4):315-23. PubMed ID: 20640583
[TBL] [Abstract][Full Text] [Related]
15. Eicosapentaenoic acid suppresses cisplatin-induced muscle atrophy by attenuating the up-regulated gene expression of ubiquitin.
Ikeno Y; Inomata M; Tsukimura Y; Suzuki Y; Takeuchi H; Harada Y; Kon R; Ikarashi N; Chiba Y; Yamada T; Kamei J; Sakai H
J Nutr Biochem; 2022 May; 103():108953. PubMed ID: 35121023
[TBL] [Abstract][Full Text] [Related]
16. Baicalin, a component of Scutellaria baicalensis, alleviates anorexia and inhibits skeletal muscle atrophy in experimental cancer cachexia.
Li B; Wan L; Li Y; Yu Q; Chen P; Gan R; Yang Q; Han Y; Guo C
Tumour Biol; 2014 Dec; 35(12):12415-25. PubMed ID: 25195133
[TBL] [Abstract][Full Text] [Related]
17. Penta-O-galloyl-β-D-glucose from Paeonia lactiflora Pall. root extract enhances the expression of skin barrier genes via EGR3.
Kim KH; Shim JS; Kim HJ; Son ED
J Ethnopharmacol; 2020 Feb; 248():112337. PubMed ID: 31655148
[TBL] [Abstract][Full Text] [Related]
18. Involvement of NF-κB and muscle specific E3 ubiquitin ligase MuRF1 in cigarette smoke-induced catabolism in C2 myotubes.
Kaisari S; Rom O; Aizenbud D; Reznick AZ
Adv Exp Med Biol; 2013; 788():7-17. PubMed ID: 23835952
[TBL] [Abstract][Full Text] [Related]
19. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
[TBL] [Abstract][Full Text] [Related]
20. Targeted ablation of the cellular inhibitor of apoptosis 1 (cIAP1) attenuates denervation-induced skeletal muscle atrophy.
Lala-Tabbert N; Lejmi-Mrad R; Timusk K; Fukano M; Holbrook J; St-Jean M; LaCasse EC; Korneluk RG
Skelet Muscle; 2019 May; 9(1):13. PubMed ID: 31126323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
